HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lane Lawyers Plan To Challenge FDA Restitution Power Under FD&C Act

This article was originally published in The Tan Sheet

Executive Summary

Lane Labs-USA plans to appeal a permanent injunction on sales of supplements marketed as cancer therapies handed down by a New Jersey federal court, according to Lane attorney Mark Ullman of New York-based Ullman, Shapiro and Ullman

You may also be interested in...

Cannon Backs FSA Supplement Coverage; NNFA Urges Public Involvement

Industry should continue to press for coverage of supplements under health savings and flexible spending accounts, Rep. Chris Cannon (R-Utah) said at the National Nutritional Food Association's Natural Products Convention in Las Vegas July 18

Lane Labs To Pay Consumer Restitution Under Permanent Injunction

The seven-year struggle between FDA and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 9

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts